Loading…

Efficacy of Serum Antithrombin III Rest in Patients With Severe Traumatic Brain Injury

Immune reactions following traumatic brain injury (TBI) cause many complications, including intravascular dissemination. Antithrombin III (AT-III) plays an important role in suppressing abnormal clot formation and ensuring hemostasis. Therefore, we investigated the efficacy of serum AT-III in patien...

Full description

Saved in:
Bibliographic Details
Published in:Korean journal of neurotrauma 2023, 19(2), , pp.234-241
Main Authors: Hee Seung Noh, Sun Geon Yoon, Kyunghak Choi, Kyu-Hyouck Kyung, Min Soo Kim
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 241
container_issue
container_start_page 234
container_title Korean journal of neurotrauma
container_volume
creator Hee Seung Noh
Sun Geon Yoon
Kyunghak Choi
Kyu-Hyouck Kyung
Min Soo Kim
description Immune reactions following traumatic brain injury (TBI) cause many complications, including intravascular dissemination. Antithrombin III (AT-III) plays an important role in suppressing abnormal clot formation and ensuring hemostasis. Therefore, we investigated the efficacy of serum AT-III in patients with severe TBI. KCI Citation Count: 0
doi_str_mv 10.13004/kjnt.2023.19.e29
format article
fullrecord <record><control><sourceid>nrf</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10270349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_kci_go_kr_ARTI_10270349</sourcerecordid><originalsourceid>FETCH-nrf_kci_oai_kci_go_kr_ARTI_102703493</originalsourceid><addsrcrecordid>eNqVi8FKAzEURUNRsGg_wN1bCzMmL0GTZS0VZyd1aJchDolmppOBJFPo35uKP-Dd3AP3XELuGa0Zp1Q8Dn3INVLkNVO1RbUgS0QpK0TBry7MRSWVUjdklVJPS6QU7AmXZL91znemO8Pk4MPGeYR1yD5_x2n89AGapoGdTRkKv5vsbcgJDmUv8slGC20081iGDl6iuRxCP8fzHbl25pjs6q9vycPrtt28VSE6PXReT8b_9tekh6jXu7bRjOIz5ULxf8k_1l5M7g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy of Serum Antithrombin III Rest in Patients With Severe Traumatic Brain Injury</title><source>PubMed Central</source><creator>Hee Seung Noh ; Sun Geon Yoon ; Kyunghak Choi ; Kyu-Hyouck Kyung ; Min Soo Kim</creator><creatorcontrib>Hee Seung Noh ; Sun Geon Yoon ; Kyunghak Choi ; Kyu-Hyouck Kyung ; Min Soo Kim</creatorcontrib><description>Immune reactions following traumatic brain injury (TBI) cause many complications, including intravascular dissemination. Antithrombin III (AT-III) plays an important role in suppressing abnormal clot formation and ensuring hemostasis. Therefore, we investigated the efficacy of serum AT-III in patients with severe TBI. KCI Citation Count: 0</description><identifier>ISSN: 2234-8999</identifier><identifier>EISSN: 2288-2243</identifier><identifier>DOI: 10.13004/kjnt.2023.19.e29</identifier><language>eng</language><publisher>대한신경손상학회</publisher><subject>신경외과학</subject><ispartof>Korean Journal of Neurotrauma, 2023, 19(2), , pp.234-241</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002976482$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Hee Seung Noh</creatorcontrib><creatorcontrib>Sun Geon Yoon</creatorcontrib><creatorcontrib>Kyunghak Choi</creatorcontrib><creatorcontrib>Kyu-Hyouck Kyung</creatorcontrib><creatorcontrib>Min Soo Kim</creatorcontrib><title>Efficacy of Serum Antithrombin III Rest in Patients With Severe Traumatic Brain Injury</title><title>Korean journal of neurotrauma</title><description>Immune reactions following traumatic brain injury (TBI) cause many complications, including intravascular dissemination. Antithrombin III (AT-III) plays an important role in suppressing abnormal clot formation and ensuring hemostasis. Therefore, we investigated the efficacy of serum AT-III in patients with severe TBI. KCI Citation Count: 0</description><subject>신경외과학</subject><issn>2234-8999</issn><issn>2288-2243</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqVi8FKAzEURUNRsGg_wN1bCzMmL0GTZS0VZyd1aJchDolmppOBJFPo35uKP-Dd3AP3XELuGa0Zp1Q8Dn3INVLkNVO1RbUgS0QpK0TBry7MRSWVUjdklVJPS6QU7AmXZL91znemO8Pk4MPGeYR1yD5_x2n89AGapoGdTRkKv5vsbcgJDmUv8slGC20081iGDl6iuRxCP8fzHbl25pjs6q9vycPrtt28VSE6PXReT8b_9tekh6jXu7bRjOIz5ULxf8k_1l5M7g</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Hee Seung Noh</creator><creator>Sun Geon Yoon</creator><creator>Kyunghak Choi</creator><creator>Kyu-Hyouck Kyung</creator><creator>Min Soo Kim</creator><general>대한신경손상학회</general><scope>ACYCR</scope></search><sort><creationdate>202306</creationdate><title>Efficacy of Serum Antithrombin III Rest in Patients With Severe Traumatic Brain Injury</title><author>Hee Seung Noh ; Sun Geon Yoon ; Kyunghak Choi ; Kyu-Hyouck Kyung ; Min Soo Kim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-nrf_kci_oai_kci_go_kr_ARTI_102703493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>신경외과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hee Seung Noh</creatorcontrib><creatorcontrib>Sun Geon Yoon</creatorcontrib><creatorcontrib>Kyunghak Choi</creatorcontrib><creatorcontrib>Kyu-Hyouck Kyung</creatorcontrib><creatorcontrib>Min Soo Kim</creatorcontrib><collection>Korean Citation Index</collection><jtitle>Korean journal of neurotrauma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hee Seung Noh</au><au>Sun Geon Yoon</au><au>Kyunghak Choi</au><au>Kyu-Hyouck Kyung</au><au>Min Soo Kim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Serum Antithrombin III Rest in Patients With Severe Traumatic Brain Injury</atitle><jtitle>Korean journal of neurotrauma</jtitle><date>2023-06</date><risdate>2023</risdate><spage>234</spage><epage>241</epage><pages>234-241</pages><issn>2234-8999</issn><eissn>2288-2243</eissn><abstract>Immune reactions following traumatic brain injury (TBI) cause many complications, including intravascular dissemination. Antithrombin III (AT-III) plays an important role in suppressing abnormal clot formation and ensuring hemostasis. Therefore, we investigated the efficacy of serum AT-III in patients with severe TBI. KCI Citation Count: 0</abstract><pub>대한신경손상학회</pub><doi>10.13004/kjnt.2023.19.e29</doi></addata></record>
fulltext fulltext
identifier ISSN: 2234-8999
ispartof Korean Journal of Neurotrauma, 2023, 19(2), , pp.234-241
issn 2234-8999
2288-2243
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_10270349
source PubMed Central
subjects 신경외과학
title Efficacy of Serum Antithrombin III Rest in Patients With Severe Traumatic Brain Injury
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T23%3A27%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-nrf&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Serum%20Antithrombin%20III%20Rest%20in%20Patients%20With%20Severe%20Traumatic%20Brain%20Injury&rft.jtitle=Korean%20journal%20of%20neurotrauma&rft.au=Hee%20Seung%20Noh&rft.date=2023-06&rft.spage=234&rft.epage=241&rft.pages=234-241&rft.issn=2234-8999&rft.eissn=2288-2243&rft_id=info:doi/10.13004/kjnt.2023.19.e29&rft_dat=%3Cnrf%3Eoai_kci_go_kr_ARTI_10270349%3C/nrf%3E%3Cgrp_id%3Ecdi_FETCH-nrf_kci_oai_kci_go_kr_ARTI_102703493%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true